ArticleBMC oral health2025
Three-dimensional scaffold-free periodontal ligament stem cell pellets for alveolar ridge preservation: an in vitro and in vivo study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cell pellets promote periodontal bone regeneration in furcation involvement by regulating macrophage polarization through TGF-β1 secretion.BMC oral health · 2026Article
- MicroRNAs in periodontal disease: from pathogenic mechanisms and RANKL/OPG regulation to nanoparticle delivery and personalized medicine.Frontiers in immunology · 2026Review
- Diosmin-Capped Silver Nanoparticles Promote Osteogenic Differentiation of Human Periodontal Ligament Stem Cells: Box-Behnken Optimization and in vitro Evaluation.International journal of nanomedicine · 2026Article
- Oral stem cells in combination with hydrogels as biomimetic bioactive platforms for periodontal tissue engineering.Frontiers in oral health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesThis study aimed to investigate the regenerative potential of a novel three-dimensional, scaffold-free human periodontal ligament stem cell-derived cell pellet (PDLSC-CP) for bone tissue regeneration and alveolar ridge preservation. The study evaluated the efficacy of PDLSC-CP in vitro and in vivo, comparing it with traditional cell sheets (PDLSC-CS).
methodsPDLSCs were isolated from extracted premolars and characterized for their mesenchymal stem cell properties, including fibroblast-like morphology, colony-forming ability, multilineage differentiation potential, and specific surface marker expression. PDLSC-CP and PDLSC-CS were constructed and compared through histomorphological, immunofluorescence, real-time PCR, and western blot analyses. In vivo evaluations were performed using rat calvarial defect models and canine alveolar ridge preservation models, with micro-CT and histological analyses to assess bone regeneration and ridge preservation.
resultsPDLSC-CP demonstrated superior histomorphological characteristics, including higher cell density, richer extracellular matrix (ECM), and enhanced osteogenic potential compared to PDLSC-CS. In vitro analyses revealed significantly elevated expression of ECM proteins (fibronectin, collagen type I) and osteogenic markers in PDLSC-CP. In vivo evaluations confirmed its remarkable capacity for bone regeneration in rat calvarial defects and alveolar ridge preservation in canine models. Micro-CT and histological analyses showed that PDLSC-CP promoted extensive and dense new bone formation, with improved bone volume fraction, trabecular thickness, and mineralization.
conclusionsThe findings highlight the therapeutic potential of PDLSC-CP as a promising tool for bone tissue engineering and regenerative medicine. Its ability to enhance bone regeneration and alveolar ridge preservation underscores its clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.